Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “EUGENOL”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 37 records · Page 2Linked to original sources

Effects of eugenol and non-eugenol endodontic fillers on short post retention, in primary anterior teeth: an in vitro study.

The aim of this study was to measure in vitro the tensile bond strength of short composite posts in anterior primary teeth filled with calcium hydroxide and eugenol-based endodontic filling materials. Means of tensile strength ranged from 2.66 to 3.56 MPa. Statistical analysis (ANOVA) revealed that there were no statistically significant differences between the groups. It was concluded that the type of filling material used in the endodontic treatment did not interfere with the tensile strength.

Calcium Hydroxide↗

Oxidation of eugenol to form DNA adducts and 8-hydroxy-2'-deoxyguanosine: role of quinone methide derivative in DNA adduct formation.

We have investigated the activation of eugenol to form DNA adducts and oxidative base damage. Treatment of myeloperoxidase containing HL-60 cells with eugenol, produced a dose-dependent formation of three DNA adducts as detected with P1-enhanced 32P-post-labeling. Incubation of HL-60 cells with the combination of 100 microM eugenol and 100 microM H2O2 potentiated the levels of DNA adduct in HL-60 cells by 14-fold, which suggests peroxidase activation in adduct formation. In vitro activation of eugenol with either horseradish peroxidase or myeloperoxidase and H2O2 produced three DNA adducts that were inhibited by the addition of either ascorbic acid or glutathione, by 66 and 90%, respectively. The DNA adducts formed in HL-60 cells treated with eugenol were the same as those formed by in vitro peroxidase activation. In addition to adduct formation, peroxidase activation of eugenol produced a 2- to 3-fold increase in the level of oxidative base damage. Eugenol quinone methide was prepared by Ag(I)oxide oxidation of eugenol. Peroxidase activation of eugenol gave a product that had the same UV spectrum as eugenol quinone methide, which suggests that it was one of the products. Reaction of eugenol quinone methide with either DNA or deoxyguanosine-3'-phosphate produced two principal adducts (2 and 4). When DNA adduct 2 formed by incubation of eugenol quinone methide with deoxyguanosine-3'-phosphate was compared with DNA 2 adduct formed in HL-60 cells treated with eugenol results demonstrated that they were the same. This suggests that eugenol quinone methide is one of the reactive intermediates leading to DNA adduct formation in cells. Activation of eugenol with 10 microM copper sulfate resulted in the production of one principal (2) and several minor adducts. DNA adduct 2 formed by activation of eugenol with copper sulfate was the same as DNA adduct 2 formed by either peroxidase activation of eugenol or by reactions with eugenol quinone methide, which indicates that the reactive intermediates generated by these activation systems were similar. Copper sulfate produced a 95-fold increase in the level of oxidative base damage, which was significantly inhibited by the addition of either bathocuproinedisulphonic acid or catalase. The formation of oxidative base damage was consistent with a Fenton reaction mechanism. Our results demonstrate that eugenol can be activated to form both DNA adducts and oxidative base damage. We propose that the formation of this DNA damage may contribute to the observed toxic properties of eugenol.

8-Hydroxy-2'-Deoxyguanosine↗

Eugenol diffusion through dentin related to dentin hydraulic conductance.

OBJECTIVES: The purpose of this study was (1) to find an easy way of evaluating the concentration of eugenol in cell culture fluids; (2) to confirm the relationship between the concentration and the cytotoxicity of eugenol in vitro; (3) to evaluate the cytotoxicity of four temporary eugenol-based filling materials: IRM, super EBA, Kalsogen and zinc oxide-eugenol cement; and (4) to establish a relationship between dentin permeability, eugenol diffusion and cytotoxicity. METHODS: (1) The concentration of eugenol was measured with a spectrofluorimeter; (2) the cell viability of L 929 cells cultivated for 24 h with eugenol-containing medium was evaluated by the MTT assay; (3) after measurement of hydraulic conductance, occlusal cavities in human teeth in vitro were filled with the restorative materials. The cytotoxicity was measured with undiluted test medium and with various dilutions in culture medium; (4) after Lp measurement, the eugenol concentration in the media in the pulp chamber that diffused from IRM and 10(3) mol/l eugenol solution was measured. RESULTS: (1) A proportional relationship (p = 0.001 and r = 1) was found between the concentration of eugenol; (2) eugenol started to be cytotoxic at 10(-5) mol/l and killed 95% of the cells at 10(-3) mol/l; (3) zinc oxide-eugenol cement was the most cytotoxic filling material when tested with the 1:100 dilution; (4) a significant relationship was found between Lp and cytotoxicity (p = 0.04) depending on the dilution of the test medium. A significant relationship was found between Lp and eugenol diffusion from a 10(-3) mol/l solution (p = 0.03) but not between Lp and eugenol diffusing from solid IRM (non significant). SIGNIFICANCE: Eugenol diffusion from zinc oxide-eugenol cement appears to depend more on the role of hydrolysis of eugenol from zinc oxide-eugenol cement than on dentin permeability.

Analysis of Variance↗

Effect of eugenol on the genotoxicity of established mutagens in the liver.

The influence of in vivo treatment with eugenol on established mutagens was studied to determine whether eugenol has antigenotoxic potential. The effects of eugenol in rats was investigated in the unscheduled DNA synthesis (UDS) assay with established mutagens and the Salmonella typhimurium mutagenicity assay. In addition, the effect of in vivo treatment with eugenol on benzo[a]pyrene (B[a]P)-induced genotoxicity in human hepatoma cell line Hep G2 was investigated in the single-cell gel electrophoresis assay. The mutagenicity of B[a]P in the S. typhimurium mutagenicity assay was lower in liver S-9 fractions from control rats. Incubation of liver S-9 fractions from eugenol-treated rats with dimethylbenzanthracene (DMBA) had no antimutagenic effect. Eugenol did not modify UDS activity in hepatocytes isolated from rats pretreated with eugenol orally after exposure of these cells in vitro to DMBA and aflatoxin B1. Four different treatment schemes of combinations of B[a]P and eugenol were examined in Hep G2 cells: pre-treatment with eugenol; simultaneous treatment with eugenol and B[a]P; a combination of these (pretreatment/simultaneous treatment); and post-treatment with eugenol. An increase in the genotoxicity of B[a]P was found in Hep G2 cells. No effect of eugenol on the genotoxicity of B[a]P was found with the pre- and post-treatments. It is concluded that the effect of eugenol on genotoxicity induced by established mutagens is not univocal; in vivo treatment of rats with eugenol resulted in a reduction of the mutagenicity of B[a]P in the S. typhimurium mutagenicity assay, while in the UDS assay no effect of eugenol was found. In vitro treatment of cultured cells with eugenol resulted in an increase in genotoxicity of B[a]P. These findings indicate that there is only limited support for the antigenotoxic potential of eugenol in vivo.

9,10-Dimethyl-1,2-benzanthracene↗